Identification of a Novel MPRIP-ROS1 Fusion and Clinical Efficacy of Crizotinib in an Advanced Lung Adenocarcinoma Patient: A Case Report

Identification of a Novel MPRIP-ROS1 Fusion and Clinical Efficacy of Crizotinib in an Advanced Lung Adenocarcinoma Patient: A Case Report

Yun Shu,1,* Hui Li,2,* Hongjuan Shang,1 Jun Chen,1 Xiaoxing Su,2 Wei Le,1 Yan Lei,2 Liming Tao,1 Cailiang Zou,1 Wendy Wu2 1Department of Medical Oncology, Third People’s Hospital of Jiujiang City, Jiujiang 332000, People’s Republic of China; 2Berry Oncology Corporation, Fuzhou 35...

Full description

Bibliographic Details
Main Authors: Shu Y, Li H, Shang H, Chen J, Su X, Le W, Lei Y, Tao L, Zou C, Wu W
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
mprip-ros1 fusion
advanced lung adenocarcinoma
sensitive to crizotinib
next-generation sequencing
Online Access:https://www.dovepress.com/identification-of-a-novel-mprip-ros1-fusion-and-clinical-efficacy-of-c-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/identification-of-a-novel-mprip-ros1-fusion-and-clinical-efficacy-of-c-peer-reviewed-article-OTT

Similar Items